These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 36556972)

  • 21. Biology and diagnosis of aberrant crypt foci.
    Lopez-Ceron M; Pellise M
    Colorectal Dis; 2012 Apr; 14(4):e157-64. PubMed ID: 22182185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromoendoscopy with a Standard-Resolution Colonoscope for Evaluation of Rectal Aberrant Crypt Foci.
    Kowalczyk M; Siermontowski P; Mucha D; Ambroży T; Orłowski M; Zinkiewicz K; Kurpiewski W; Paśnik K; Kowalczyk I; Pedrycz A
    PLoS One; 2016; 11(2):e0148286. PubMed ID: 26886097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histomorphology of aberrant crypt foci in colorectal carcinoma.
    Norlida AO; Phang KS
    Malays J Pathol; 2010 Dec; 32(2):111-6. PubMed ID: 21329182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer Risk.
    Quintanilla I; López-Cerón M; Jimeno M; Cuatrecasas M; Zabalza M; Moreira L; Alonso V; Rodríguez de Miguel C; Muñoz J; Castellvi-Bel S; Llach J; Castells A; Balaguer F; Camps J; Pellisé M
    Clin Transl Gastroenterol; 2019 Jun; 10(6):e00047. PubMed ID: 31136360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukotriene Receptor Antagonist Therapy for the Chemoprevention of Human Rectal Aberrant Crypt Foci: Nonrandomized, Open-Label, Controlled Trial.
    Higurashi T; Ashikari K; Tamura S; Saigusa Y; Takatsu T; Misawa N; Yoshihara T; Matsuura T; Fuyuki A; Ohkubo H; Kessoku T; Hosono K; Yoneda M; Nakajima A
    Cancer Prev Res (Phila); 2022 Oct; 15(10):661-668. PubMed ID: 36083855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant crypt foci: endoscopic assessment and cell kinetics characterization.
    Figueiredo P; Donato M; Urbano M; Goulão H; Gouveia H; Sofia C; Leitão M; Freitas D
    Int J Colorectal Dis; 2009 Apr; 24(4):441-50. PubMed ID: 18769883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant crypt focus size predicts distal polyp histopathology.
    Kim J; Ng J; Arozulllah A; Ewing R; Llor X; Carroll RE; Benya RV
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1155-62. PubMed ID: 18483337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer.
    Shpitz B; Klein E; Buklan G; Neufeld D; Nissan A; Freund HR; Grankin M; Bernheim J
    Gut; 2003 Nov; 52(11):1598-601. PubMed ID: 14570729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic disease.
    Bouzourene H; Chaubert P; Seelentag W; Bosman FT; Saraga E
    Hum Pathol; 1999 Jan; 30(1):66-71. PubMed ID: 9923929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter study of prevalence and risk factors for aberrant crypt foci.
    Mutch MG; Schoen RE; Fleshman JW; Rall CJ; Dry S; Seligson D; Charabaty A; Chia D; Umar A; Viner J; Hawk E; Pinsky PF
    Clin Gastroenterol Hepatol; 2009 May; 7(5):568-74. PubMed ID: 19418605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of human aberrant crypt foci and correlation with risk factors for colorectal cancer.
    Ohkubo H; Takahashi H; Yamada E; Sakai E; Higurashi T; Uchiyama T; Hosono K; Endo H; Taguri M; Nakajima A
    Oncol Rep; 2012 May; 27(5):1475-80. PubMed ID: 22246586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoprevention of colorectal cancer.
    Niitsu Y; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Kukitsu T; Takanashi K; Ishiwatari H; Abe T; Kogawa T; Takahashi M; Matsunaga T; Kato J
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S40-3. PubMed ID: 15309513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of High-Risk Aberrant Crypt Foci and Mucin-Depleted Foci in the Human Colon With Study of Colon Cancer Stem Cell Markers.
    Gupta B; Das P; Ghosh S; Manhas J; Sen S; Pal S; Sahni P; Upadhyay AD; Panda SK; Gupta SD
    Clin Colorectal Cancer; 2017 Sep; 16(3):204-213. PubMed ID: 27789195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?
    Gupta AK; Schoen RE
    Curr Opin Gastroenterol; 2009 Jan; 25(1):59-65. PubMed ID: 19114775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship of aging and tobacco use with the development of aberrant crypt foci in a predominantly African-American population.
    Moxon D; Raza M; Kenney R; Ewing R; Arozullah A; Mason JB; Carroll RE
    Clin Gastroenterol Hepatol; 2005 Mar; 3(3):271-8. PubMed ID: 15765447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant crypt foci in human colons: distribution and histomorphologic characteristics.
    Shpitz B; Bomstein Y; Mekori Y; Cohen R; Kaufman Z; Neufeld D; Galkin M; Bernheim J
    Hum Pathol; 1998 May; 29(5):469-75. PubMed ID: 9596270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum.
    Gillen DL; Meyskens FL; Morgan TR; Zell JA; Carroll R; Benya R; Chen WP; Mo A; Tucker C; Bhattacharya A; Huang Z; Arcilla M; Wong V; Chung J; Gonzalez R; Rodriguez LM; Szabo E; Rosenberg DW; Lipkin SM
    Cancer Prev Res (Phila); 2015 Mar; 8(3):222-30. PubMed ID: 25604134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One year recurrence of aberrant crypt foci.
    Pinsky PF; Fleshman J; Mutch M; Rall C; Charabaty A; Seligson D; Dry S; Umar A; Schoen RE
    Cancer Prev Res (Phila); 2010 Jul; 3(7):839-43. PubMed ID: 20570885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proximal Aberrant Crypt Foci Associate with Synchronous Neoplasia and Are Primed for Neoplastic Progression.
    Drew DA; Mo A; Grady JJ; Stevens RG; Levine JB; Brenner BM; Anderson JC; Forouhar F; O'Brien MJ; Devers TJ; Rosenberg DW
    Mol Cancer Res; 2018 Mar; 16(3):486-495. PubMed ID: 29222172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.